The article highlights Celestica's strong growth prospects, particularly in the CCS segment, which is expected to continue outgrowing ATS. This growth is leading to margin expansion and improved cash flow conversion, which are positive indicators for the company's financial health. The focus on inventory reduction further supports this positive outlook by improving net working capital intensity.